[go: up one dir, main page]

MX2019003148A - Base de datos, de datos moleculares, omicos, de inmunoterapia, metabolicos, epigeneticos y clinicos, integrados. - Google Patents

Base de datos, de datos moleculares, omicos, de inmunoterapia, metabolicos, epigeneticos y clinicos, integrados.

Info

Publication number
MX2019003148A
MX2019003148A MX2019003148A MX2019003148A MX2019003148A MX 2019003148 A MX2019003148 A MX 2019003148A MX 2019003148 A MX2019003148 A MX 2019003148A MX 2019003148 A MX2019003148 A MX 2019003148A MX 2019003148 A MX2019003148 A MX 2019003148A
Authority
MX
Mexico
Prior art keywords
clinical
molecular
omicos
epigenetic
immunotherapy
Prior art date
Application number
MX2019003148A
Other languages
English (en)
Other versions
MX389484B (es
Inventor
E Giusti Kathryn
GIUSTI Paul
Auclair Daniel
Original Assignee
The Multiple Myeloma Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Multiple Myeloma Res Foundation Inc filed Critical The Multiple Myeloma Res Foundation Inc
Publication of MX2019003148A publication Critical patent/MX2019003148A/es
Publication of MX389484B publication Critical patent/MX389484B/es

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/40—Population genetics; Linkage disequilibrium
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Data Mining & Analysis (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Bioethics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La descripción describe un sistema de datos de registro de paciente que se pueden utilizar para agregar parámetros clínicos, moleculares inmunes implicados en el inicio de la enfermedad, progresión, y respuesta al tratamiento. La descripción puede permitir que los participantes, investigadores, y médicos visualicen datos basados en los parámetros, tal como datos demográficos del paciente y del sistema inmunitario.
MX2019003148A 2017-11-13 2018-11-13 Base de datos, de datos moleculares, omicos, de inmunoterapia, metabolicos, epigeneticos y clinicos, integrados MX389484B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762585190P 2017-11-13 2017-11-13
US201862699411P 2018-07-17 2018-07-17
PCT/US2018/060751 WO2019094935A1 (en) 2017-11-13 2018-11-13 Integrated, molecular, omics, immunotherapy, metabolic, epigenetic, and clinical database

Publications (2)

Publication Number Publication Date
MX2019003148A true MX2019003148A (es) 2019-05-27
MX389484B MX389484B (es) 2025-03-20

Family

ID=66433597

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019003148A MX389484B (es) 2017-11-13 2018-11-13 Base de datos, de datos moleculares, omicos, de inmunoterapia, metabolicos, epigeneticos y clinicos, integrados

Country Status (9)

Country Link
US (2) US11069431B2 (es)
EP (1) EP3513280A4 (es)
JP (1) JP7019200B2 (es)
KR (1) KR102424222B1 (es)
CN (2) CN110268383A (es)
AU (1) AU2018327221A1 (es)
CA (1) CA3036161C (es)
MX (1) MX389484B (es)
WO (1) WO2019094935A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11093640B2 (en) 2018-04-12 2021-08-17 International Business Machines Corporation Augmenting datasets with selected de-identified data records
US10770171B2 (en) * 2018-04-12 2020-09-08 International Business Machines Corporation Augmenting datasets using de-identified data and selected authorized records
AU2020313915A1 (en) * 2019-07-12 2022-02-24 Tempus Ai, Inc. Adaptive order fulfillment and tracking methods and systems
CN110610750B (zh) * 2019-08-14 2022-02-22 首都医科大学附属北京同仁医院 眼病临床数据处理方法及系统
CN110716041B (zh) * 2019-10-23 2023-04-18 郑州大学 一种用于胃癌早期筛查和诊断的血清蛋白标志物、试剂盒及检测方法
KR20230058084A (ko) * 2020-08-21 2023-05-02 박용남 대규모 감염질환의 비대면 선별진료에 관한 개인의료기록 시스템 및 방법
US20220246243A1 (en) * 2021-02-02 2022-08-04 Alan John Rosenbloom Computerized Fluidic System and Methods of Use for Characterization of Molecular Networks in Complex Systems with Automated Sampling, Data Collection, Assays and Data Analytics
WO2022217161A1 (en) * 2021-04-09 2022-10-13 Lindsay Lifescience Llc Systems and methods for predicting a condition
WO2023077015A2 (en) * 2021-10-27 2023-05-04 Iovance Biotherapeutics, Inc. Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
US11705230B1 (en) 2021-11-30 2023-07-18 Vignet Incorporated Assessing health risks using genetic, epigenetic, and phenotypic data sources
US11901083B1 (en) 2021-11-30 2024-02-13 Vignet Incorporated Using genetic and phenotypic data sets for drug discovery clinical trials
WO2024025923A1 (en) * 2022-07-26 2024-02-01 Washington University Methods for selection of cancer patients for anti-angiogenic and immune checkpoint blockade therapies and combinations thereof
CN115389766B (zh) * 2022-08-29 2023-09-22 深圳市瑞格生物科技有限公司 用于诊断神经母细胞瘤是否发生骨髓浸润的标志物及其应用
US20240249847A1 (en) * 2023-01-20 2024-07-25 Institute For Systems Biology Omics-inferred body index method and system
CN116230247A (zh) * 2023-05-10 2023-06-06 南京品生医疗科技有限公司 数据分析方法、装置、电子设备及存储介质

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6196970B1 (en) 1999-03-22 2001-03-06 Stephen J. Brown Research data collection and analysis
US6013445A (en) 1996-06-06 2000-01-11 Lynx Therapeutics, Inc. Massively parallel signature sequencing by ligation of encoded adaptors
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
EP1591541B1 (en) 1997-04-01 2012-02-15 Illumina Cambridge Limited Method of nucleic acid sequencing
EP0975802B1 (en) 1997-04-01 2004-06-23 Manteia S.A. Method of nucleic acid sequencing
US6128603A (en) 1997-09-09 2000-10-03 Dent; Warren T. Consumer-based system and method for managing and paying electronic billing statements
US7734656B2 (en) 1998-02-24 2010-06-08 Luc Bessette System and method for electronically managing medical data files in order to facilitate genetic research
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
AR021833A1 (es) 1998-09-30 2002-08-07 Applied Research Systems Metodos de amplificacion y secuenciacion de acido nucleico
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
AU6106300A (en) 1999-07-15 2001-02-05 Unus Technology Llc System, apparatus, and methods for developing and delivering health information
JP2002024385A (ja) 2000-06-30 2002-01-25 Coreflow Technologies:Kk 遺伝子情報管理システム及びその管理方法
US20020046054A1 (en) 2000-08-28 2002-04-18 Morand Patrick G. Use of blood and plasma donor samples and data in the drug discovery process
GB0021977D0 (en) 2000-09-07 2000-10-25 Pyrosequencing Ab Method of sequencing DNA
AR031640A1 (es) 2000-12-08 2003-09-24 Applied Research Systems Amplificacion isotermica de acidos nucleicos en un soporte solido
US20080133270A1 (en) 2001-01-29 2008-06-05 Michelson Leslie Dennis Systems and Methods for Selecting and Recruiting Investigators and Subjects for Clinical Studies
US8114591B2 (en) 2001-03-09 2012-02-14 Dna Electronics Ltd. Sensing apparatus and method
GB0105831D0 (en) 2001-03-09 2001-04-25 Toumaz Technology Ltd Method for dna sequencing utilising enzyme linked field effect transistors
CA2377213A1 (en) 2001-03-20 2002-09-20 Ortho-Clinical Diagnostics, Inc. Method for providing clinical diagnostic services
US7415447B2 (en) 2001-04-02 2008-08-19 Invivodata, Inc. Apparatus and method for prediction and management of participant compliance in clinical research
WO2002083865A2 (en) * 2001-04-13 2002-10-24 First Genetic Trust Methods and systems for managing informed consent processes
US20040002090A1 (en) 2002-03-05 2004-01-01 Pascal Mayer Methods for detecting genome-wide sequence variations associated with a phenotype
AU2002950878A0 (en) 2002-08-20 2002-09-12 Proteome Systems Intellectual Property Pty Ltd Method for diagnosing disorders
JP2004185192A (ja) 2002-12-02 2004-07-02 Naoaki Ishii 健康情報の解析・研究及び健康維持・長寿実現のための総合支援システム
US8131475B2 (en) * 2003-09-03 2012-03-06 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods for identifying, diagnosing, and predicting survival of lymphomas
JP2007526772A (ja) 2004-02-27 2007-09-20 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ インサイチュー配列決定用ポロニー蛍光ビーズ
US8135595B2 (en) 2004-05-14 2012-03-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Computer systems and methods for providing health care
DE602005027700D1 (de) 2004-05-25 2011-06-09 Helicos Biosciences Corp Verfahren zur nukleinsäureimmobilisierung
GB2416210B (en) 2004-07-13 2008-02-20 Christofer Toumazou Ion sensitive field effect transistors
US7276720B2 (en) 2004-07-19 2007-10-02 Helicos Biosciences Corporation Apparatus and methods for analyzing samples
US20060024678A1 (en) 2004-07-28 2006-02-02 Helicos Biosciences Corporation Use of single-stranded nucleic acid binding proteins in sequencing
JP4718814B2 (ja) 2004-09-17 2011-07-06 株式会社東芝 医療情報提供システム
KR100614033B1 (ko) 2004-11-30 2006-08-22 경북대학교 산학협력단 온라인 의료정보 제공 시스템 및 방법
JP2006202235A (ja) 2005-01-24 2006-08-03 Nara Institute Of Science & Technology 経時的現象発生解析装置及び経時的現象発生解析方法
KR20070112785A (ko) 2005-02-01 2007-11-27 에이젠코트 바이오사이언스 코오포레이션 비드-기초 서열화를 위한 시약, 방법, 및 라이브러리
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US7894993B2 (en) 2005-09-08 2011-02-22 The Invention Science Fund I, Llc Data accessing techniques related to tissue coding
JP2007199948A (ja) 2006-01-25 2007-08-09 Dainakomu:Kk 疾患リスク情報表示装置およびプログラム
WO2007092538A2 (en) 2006-02-07 2007-08-16 President And Fellows Of Harvard College Methods for making nucleotide probes for sequencing and synthesis
US8069055B2 (en) 2006-02-09 2011-11-29 General Electric Company Predictive scheduling for procedure medicine
SG10201405158QA (en) 2006-02-24 2014-10-30 Callida Genomics Inc High throughput genome sequencing on dna arrays
US20080269476A1 (en) 2006-04-26 2008-10-30 Helicos Biosciences Corporation Molecules and methods for nucleic acid sequencing
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
US20090117549A1 (en) 2006-07-18 2009-05-07 Weihong Tan Aptamer-based methods for identifying cellular biomarkers
WO2008039998A2 (en) 2006-09-28 2008-04-03 President And Fellows Of Harvard College Methods for sequencing dna
US20080081330A1 (en) 2006-09-28 2008-04-03 Helicos Biosciences Corporation Method and devices for analyzing small RNA molecules
EP2102365A4 (en) 2006-12-29 2010-06-09 Applied Biosystems Llc ENRICHMENT THROUGH HETERODUPLEX MOLECULES
US8099298B2 (en) 2007-02-14 2012-01-17 Genelex, Inc Genetic data analysis and database tools
US20080227210A1 (en) * 2007-03-12 2008-09-18 Henry Smith Home test for glycated albumin in saliva
US20090156906A1 (en) 2007-06-25 2009-06-18 Liebman Michael N Patient-centric data model for research and clinical applications
US20090163366A1 (en) 2007-12-24 2009-06-25 Helicos Biosciences Corporation Two-primer sequencing for high-throughput expression analysis
US7767400B2 (en) 2008-02-03 2010-08-03 Helicos Biosciences Corporation Paired-end reads in sequencing by synthesis
WO2009117122A2 (en) 2008-03-19 2009-09-24 Existence Genetics Llc Genetic analysis
EP2268838A1 (en) 2008-04-11 2011-01-05 China Synthetic Rubber Corporation Methods, agents and kits for the detection of cancer
WO2009132028A1 (en) 2008-04-21 2009-10-29 Complete Genomics, Inc. Array structures for nucleic acid detection
US20100228699A1 (en) 2008-06-20 2010-09-09 Transenda International, Llc System and method for interacting with clinical trial operational data
US20100047876A1 (en) 2008-08-08 2010-02-25 President And Fellows Of Harvard College Hierarchical assembly of polynucleotides
KR20110057188A (ko) * 2008-08-27 2011-05-31 하. 룬트벡 아크티에 셀스카브 바이오마커 프로파일 측정 시스템 및 방법
WO2010025310A2 (en) 2008-08-27 2010-03-04 Westend Asset Clearinghouse Company, Llc Methods and devices for high fidelity polynucleotide synthesis
US20100184045A1 (en) 2008-09-23 2010-07-22 Helicos Biosciences Corporation Methods for sequencing degraded or modified nucleic acids
US8930212B2 (en) * 2009-07-17 2015-01-06 WAVi Patient data management apparatus for comparing patient data with ailment archetypes to determine correlation with established ailment biomarkers
CA2772929A1 (en) * 2009-09-03 2011-03-11 Genentech, Inc. Methods for treating, diagnosing, and monitoring rheumatoid arthritis
PL2504451T3 (pl) 2009-11-23 2019-09-30 Genomic Health, Inc. Sposoby przewidywania wyników klinicznych dla nowotworu
US8774494B2 (en) 2010-04-30 2014-07-08 Complete Genomics, Inc. Method and system for accurate alignment and registration of array for DNA sequencing
US20120089418A1 (en) * 2010-10-11 2012-04-12 Shwetha Ramachandra Kamath INTEGRATED INTERACTIVE SYSTEMS AND METHODS WITH SINGLE TRANSACTIONAL DATABASE AND REPORTING APPLICATION FOR eCLINICAL TRIALS
MX362132B (es) * 2011-05-10 2019-01-07 Nestec Sa Metodos para perfilado de actividad de enfermedad para manejo de terapia personalizado.
EP2718865A2 (en) 2011-06-06 2014-04-16 Koninklijke Philips N.V. Cross-modal application of combination signatures indicative of a phenotype
KR20140054037A (ko) 2011-07-13 2014-05-08 더 멀티플 마이얼로머 리서치 파운데이션, 인크. 데이터 수집 및 분배 방법
US20140335505A1 (en) 2011-09-25 2014-11-13 Theranos, Inc. Systems and methods for collecting and transmitting assay results
EP2613278A2 (en) * 2011-12-05 2013-07-10 Koninklijke Philips Electronics N.V. Retroactive extraction of clinically relevant information from patient sequencing data for clinical decision support
US20130144790A1 (en) * 2011-12-06 2013-06-06 Walter Clements Data Automation
WO2014105752A1 (en) * 2012-12-28 2014-07-03 Revon Systems, Llc Systems and methods for using electronic medical records in conjunction with patient apps
WO2014152305A1 (en) * 2013-03-14 2014-09-25 Ontomics, Inc. System and methods for personalized clinical decision support tools
JP6248326B2 (ja) 2013-10-18 2017-12-20 国立大学法人東北大学 食事型センサ、及びセンシング方法
US10175242B2 (en) * 2014-02-28 2019-01-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Personalized myeloma detection
CN106295102A (zh) * 2015-05-21 2017-01-04 杭州微云通信技术有限公司 一种基于医护人员邀约病人的智慧医疗系统和方法
CN116344071A (zh) * 2015-09-10 2023-06-27 豪夫迈·罗氏有限公司 用于整合临床护理的信息学平台
IL258309B2 (en) * 2015-09-24 2023-03-01 Caris Science Inc Method, device and product of computer software for analyzing biological data
US20170262587A1 (en) * 2016-03-09 2017-09-14 Xerox Corporation Method and system for generating patient profiles via social media services
SG11201906247WA (en) * 2017-01-10 2019-08-27 Drawbridge Health Inc Devices, systems, and methods for sample collection
CN106971071A (zh) * 2017-03-27 2017-07-21 为朔医学数据科技（北京）有限公司 一种临床决策支持系统及方法
CN106951719A (zh) * 2017-04-10 2017-07-14 荣科科技股份有限公司 临床诊断模型的构建方法及构建系统、临床诊断系统

Also Published As

Publication number Publication date
EP3513280A1 (en) 2019-07-24
MX389484B (es) 2025-03-20
US20210375412A1 (en) 2021-12-02
WO2019094935A1 (en) 2019-05-16
JP7019200B2 (ja) 2022-02-15
CN110268383A (zh) 2019-09-20
KR20200086627A (ko) 2020-07-17
AU2018327221A1 (en) 2019-05-30
KR102424222B1 (ko) 2022-07-21
US11069431B2 (en) 2021-07-20
CN114023403A (zh) 2022-02-08
US20190147989A1 (en) 2019-05-16
JP2020505659A (ja) 2020-02-20
EP3513280A4 (en) 2020-07-22
CA3036161C (en) 2023-03-28
CA3036161A1 (en) 2019-05-13

Similar Documents

Publication Publication Date Title
MX2019003148A (es) Base de datos, de datos moleculares, omicos, de inmunoterapia, metabolicos, epigeneticos y clinicos, integrados.
CL2015002127A1 (es) Sistemas y métodos para soporte de decisión clínica.
AR099535A1 (es) Interfaz de usuario de veterinario para monitorear la salud y el bienestar de un animal
MX2015012857A (es) Interfase para usuario veterinario para monitorear la salud y el bienestar de un animal.
MX2017000260A (es) Sistemas y metodos para proporcionar recomendaciones de bienenstar, nutricion y/o salud animal.
CO2017004932A2 (es) Métodos para seleccionar una línea de células t y donador de la misma para terapia celular adoptiva
PH12016500840A1 (en) Methods of using interleukin-10 for treating diseases and disorders
MX2015012585A (es) Dilatación regulada por flujo para determinar la edad vascular.
BR112016020026A8 (pt) Sistema de serviço no campo de coletar leite materno humano ou no campo da drenagem médica, unidade base, meio de dados móvel de um sistema de serviço e produto
ES2722973T3 (es) Obtención de imágenes en enfermedades neurológicas
MX2016012697A (es) Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales.
BR112016006556A2 (pt) arranjos detectáveis, sistemas para diagnóstico, e métodos para produzir e usar os mesmos
National Collaborating Centre for Mental Health (UK Autism: The management and support of children and young people on the Autism Spectrum
WO2015075240A3 (en) Method for in vitro diagnosing and prognosing of triple negative breast cancer recurrence
Seshadri et al. Physicians’ and users’ perceptions towards wearable health devices
MX2022006409A (es) Dispositivo de retención de catéter.
MX2018005080A (es) Plataforma de rastreo de resultados clinicos de pacientes.
GB2554591A (en) Clinical support system and method
SG10201807959YA (en) Medical data management system
Muljabar et al. Pengaruh pemberian informasi obat terhadap tingkat kepatuhan penggunaan antibiotika pada pasien ISPA di Puskesmas KotaGede I Yogyakarta
BR112018070547A2 (pt) agonistas de rara para o tratamento de aml e mds
BR112018010066A8 (pt) Agente estimulante do receptor 5-hidroxitriptamina 1b para intensificar potencial de enxerto in vivo
Village Introduction to special section: Psychological type and Christian ministry.
Alacacıoğlu et al. Effects of tamoxifen on premenopausal breast cancer patients in terms of anxiety, depression, quality of life and sexual satisfaction
MX2017014731A (es) Eliminacion de linfocitos b como marcador diagnostico.